Clinical Trial: DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06953089) titled 'DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors' on April 09.

Brief Summary: A Phase II, Multicenter, Open-Label Trial of DB-1311 in combination with BNT327 or DB-1305 in Participants with Advanced/Metastatic Solid Tumors

Study Start Date: June 30

Study Type: INTERVENTIONAL

Condition: Solid Tumors

Intervention: DRUG: DB-1311/BNT324

Administered I.V.

DRUG: BNT327

Administered I.V.

DRUG: DB-1305/BNT325

Administered I.V.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: DualityBio Inc.

Disclaimer: Curated by HT Syndication....